News

  • Mar 2022

    Scientific Curiosity on Display at 41st Annual Coriell Institute Science Fair

    Celebrating its 41st year, the Coriell Institute Science Fair brought more than 100 students—ranging from grades 6 through 12—together in person for the first time since 2019. Due to the COVID-19 pandemic, the fair was held virtually the past two years.

    read more

  • Feb 2022

    Applicants Wanted: Epigenetic Therapies SPORE Seeks Scientists for Research Funding

    The Epigenetic Therapies SPORE offers $50,000 grants through its Career Enhancement and Developmental Research programs to scientists interested in the epigenetics of cancer. For more information, including eligibility and award details, kindly review the Request for Applications.

    read more

  • Jan 2022

    Intro to iPSCs: A Q&A with Coriell’s Stem Cell Expert

    To meet the growing demand for iPSCs, Coriell has its own Stem Cell Lab led by Christine Grandizio. Christine’s team tackles all things iPSC: They create these cells, grow them, and coax them into becoming various adult cell types, all under careful quality control policies.

    read more

  • Jan 2022

    NHLBI Awards Coriell Institute Scientist Grant to Study Signaling Regulation of Blood Stem Cells

    The National Heart, Lung, and Blood Institute (NHLBI) has awarded a Coriell Institute for Medical Research scientist a grant to investigate the basic function of the class of stem cells that give rise to the various blood cells in hopes of improving stem cell and bone marrow transplants. This award is valued at about $2.5 million and will support this work for four years.

    read more

  • Nov 2021

    Coriell Institute for Medical Research - 2021 Annual Report

    Despite the challenges of the COVID-19 pandemic’s second year, Coriell thrived. We grew our already existing biobanks and research programs and introduced new scientists and new research initiatives. There has been great progress in each of our three pillars – biobanking, research, and community engagement –and you will find more details about each in our recently published annual report.

    read more

  • Nov 2021

    Coriell Trustee Receives Prestigious Award for Philanthropy in Arts and Humanities

    Congratulations to Frank Giordano, a longstanding member of Coriell's Board of Trustees, for being awarded the Crystal Award from Philadelphia's historic Union League. This prestigious honor recognizes Giordano's enduring commitment to and tireless effort on behalf of the arts and humanities in our region.

    read more

  • Sep 2021

    Coriell Scientists Develop Novel Assay for Sample Authentication

    In the interest of maintaining internal sample authentication without the use of forensic markers, Coriell scientists developed a new, supplementary MSAT assay that does not rely on the MSAT markers used by law enforcement. Their work was published online in the journal Biobanking and Biopreservation this month.

    read more

  • Aug 2021

    Isogenic Controls Allow for Ideal Disease Modeling

    Induced Pluripotent Stem Cell (iPSC) isogenic controls for various heritable diseases are available through the National Institute for General Medical Sciences’ Human Genetic Cell Repository at the Coriell Institute for Medical Research. These lines were created using cutting-edge CRISPR-Cas9 genome-editing technology to introduce sequence-targeted variations in established, well-characterized cell lines, thus developing and making available highly-specific research tools to the biomedical research community.

    read more

  • Aug 2021

    Coriell's Cell Line Gatekeepers: A Q&A With Coriell's Cytogenomics Team Leader

    For decades, Coriell has supplied the world with ampules and vials of cell lines and DNA samples for use in biomedical research. Swasti Kafle, Coriell's Cytogenomics Team Lead, answered a few questions about their role.

    read more

  • Jul 2021

    Coriell Teams Up with Cure Mito Foundation for Urgently Needed Fibroblasts

    The mission was clear. Kasey Woleben needed to collect of dozens of skin punches from members of her group, Cure Mito Foundation, and she needed to get fibroblast cells from those samples safely to the University of Texas Southwestern Medical Center. Unsure of where to start, Woleben turned to Coriell in September of 2020. Within just a few short months of bringing Coriell into the mix, the researchers had the cells in hand.

    read more